— Know what they know.
Not Investment Advice
Also trades as: ENLV.TA (TLV) · $vol 0M

ENLV NASDAQ

Enlivex Therapeutics Ltd.
1W: -22.7% 1M: -73.2% 3M: -92.8% YTD: -98.6% 1Y: -99.0% 3Y: -99.3% 5Y: -99.9%
$2.70
+0.10 (+3.72%)
After Hours: $2.67 (-0.03, -1.11%)
Weekly Expected Move ±14.7%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $2.7M mcap · 17M float · 4.68% daily turnover · Short 26% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 86.3% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.11 (down 34%), Enlivex Therapeutics Ltd. would be worth roughly what it owes.
Total debt $17.2M against a stock market value of $2.7M.
Distance to default 0.43 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $16.9M (short-term plus half of long-term), stock volatility 108.5%; Altman Z'' 11.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
27.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -0.4%  ·  5Y Avg: -60.1%
Cost Advantage
33
Intangibles
25
Switching Cost
23
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ENLV has No discernible competitive edge (27.8/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. Negative ROIC of -0.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2022-05-02 H.C. Wainwright — Initiated $15 — +163.6% $5.69

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

S
Oct 27, 2026
DCF
5
ROE
5
ROA
5
D/E
4
P/E
4
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ENLV receives an overall rating of S. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5), D/E (4/5), P/E (4/5), P/B (5/5).
Rating Change History
DateFromTo
2026-10-22 S- S
2026-10-12 A+ S-
2026-10-01 S- A+
2026-08-24 A+ S-
2026-07-13 S- A+
2026-07-10 A+ S-
2026-04-21 A A+
2026-04-16 A+ A
2026-04-13 A A+
2026-04-10 A+ A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
29
Earnings Quality
12
Growth
—
Value
83
Momentum
—
Safety
30
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.78
Distress Zone
Piotroski F-Score
5/9
✓ ✗ ✓ ✗ ✓ ✓ ✓ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-12.73
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB
Score: 42.6/100
Trend: Deteriorating
Earnings Quality
25/100
OCF/NI: -0.00x
Accruals: 167.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ENLV scores 1.78, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ENLV scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ENLV's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ENLV receives an estimated rating of BB (score: 42.6/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ENLV's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
0.00x
PEG
0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.62x
P/OCF
—
EV/EBITDA
-1.09x
EV/Revenue
—
EV/EBIT
-1.07x
EV/FCF
-1.34x
Earnings Yield
41198.50%
FCF Yield
-162.25%
Shareholder Yield
0.00%
Graham Number
$15707.22
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 0.0x earnings, ENLV trades at a deep value multiple. An earnings yield of 41198.5% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $15707.22 per share, suggesting a potential 9654000% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.768
NI / EBT
×
Interest Burden
-264.693
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.257
Assets / Equity
=
ROE
209.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ENLV's ROE of 209.7% is driven by

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$28890.45
Price/Value
0.00x
Margin of Safety
99.97%
Premium
-99.97%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ENLV's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $28890.45, ENLV appears undervalued with a 100% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of 0.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.70
Median 1Y
$0.56
5th Pctile
$0.10
95th Pctile
$3.05
Ann. Volatility
97.9%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
34
-5.6% YoY
Revenue / Employee
—
Profit / Employee
$36,339,059
NI: $1,235,528,000
SGA / Employee
$169,000
Avg labor cost proxy
R&D / Employee
$262,412
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -26.8% -24.0% -23.2% -33.1% -37.8% -43.8% -46.9% -47.7% -53.2% -66.9% -67.1% -61.2% -57.9% -55.9% -60.3% -55.0% -57.6% 1.3% 2.3% 2.1% 2.10%
ROA -23.7% -21.4% -21.1% -30.5% -33.5% -38.2% -40.4% -41.3% -45.5% -55.6% -57.1% -52.5% -49.3% -46.5% -52.0% -48.1% -50.1% 1.0% 1.9% 1.7% 1.67%
ROIC -11.0% -10.0% -50.3% -2.9% -67.9% -1.5% -1.1% -1.1% -1.7% -5.2% -4.2% -4.3% -4.5% -24.1% -20.8% -449.5% 87.3% -0.6% -0.8% -0.4% -0.40%
ROCE -16.5% -21.3% -26.4% -32.8% -38.0% -42.3% -48.0% -56.1% -63.2% -81.7% -81.3% -64.2% -59.8% -63.8% -70.8% -77.2% -78.0% -0.6% -0.8% -0.4% -0.42%
Gross Margin — — — — — — — — — — — — — — — — — — — — —
Operating Margin — — — — — — — — — — — — — — — — — — — — —
Net Margin — — — — — — — — — — — — — — — — — — — — —
EBITDA Margin — — — — — — — — — — — — — — — — — — — — —
FCF Margin -7.8% — — — — — — — — — — — — — — — — — — — —
OCF Margin -7.3% — — — — — — — — — — — — — — — — — — — —
ROE 3Y Avg snapshot only -13.81%
ROE 5Y Avg snapshot only -28.12%
ROA 3Y Avg snapshot only -14.68%
ROIC 3Y Avg snapshot only -48.58%
ROIC Economic snapshot only -0.40%
Cash ROA snapshot only -0.33%
Cash ROIC snapshot only -0.41%
CROIC snapshot only -0.41%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -174.01 -118.66 -79.02 -47.37 -40.99 -35.05 -33.64 -27.22 -16.23 -25.91 -40.96 -18.67 -28.32 -25.59 -22.24 -30.60 -29.53 0.41 0.11 0.00 0.000
P/S Ratio 1191.88 — — — — — — — — — — — — — — — — — — — 0.000
P/B Ratio 30.81 20.19 19.84 18.19 18.53 19.15 19.99 16.54 11.37 25.04 39.65 14.58 20.17 16.29 15.44 21.03 21.46 0.26 0.13 0.00 0.001
P/FCF -152.61 -89.57 -73.79 -43.20 -36.30 -33.94 -29.91 -26.01 -17.03 -32.04 -48.14 -24.68 -38.23 -29.23 -24.05 -31.71 -30.42 -45.85 -21.04 -0.62 -0.616
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -176.47 -87.15 -68.77 -50.85 -45.46 -41.78 -38.60 -27.13 -15.92 -29.90 -48.46 -21.86 -33.20 -24.59 -20.82 -26.32 -26.15 -35.15 -13.08 -1.09 -1.089
EV/Revenue 1153.67 — — — — — — — — — — — — — — — — — — — —
EV/EBIT -170.78 -84.68 -66.83 -49.43 -44.21 -40.53 -37.43 -26.29 -15.42 -28.90 -46.69 -20.97 -31.74 -23.71 -20.19 -25.66 -25.60 -34.36 -12.87 -1.07 -1.074
EV/FCF -147.72 -85.21 -70.08 -41.06 -35.27 -32.59 -28.99 -25.14 -16.03 -30.92 -47.12 -23.19 -36.54 -27.48 -22.53 -30.20 -28.99 -45.38 -20.60 -1.34 -1.342
Earnings Yield -0.6% -0.8% -1.3% -2.1% -2.4% -2.9% -3.0% -3.7% -6.2% -3.9% -2.4% -5.4% -3.5% -3.9% -4.5% -3.3% -3.4% 2.4% 8.8% 412.0% 411.99%
FCF Yield -0.7% -1.1% -1.4% -2.3% -2.8% -2.9% -3.3% -3.8% -5.9% -3.1% -2.1% -4.1% -2.6% -3.4% -4.2% -3.2% -3.3% -2.2% -4.8% -1.6% -1.62%
PEG Ratio snapshot only 0.000
Price/Tangible Book snapshot only 0.004
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $15707.22
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 19.08 18.32 13.81 15.44 13.08 7.92 6.89 6.17 7.34 5.57 7.86 10.06 9.71 6.84 7.20 6.41 6.43 193.24 193.24 119.39 119.386
Quick Ratio 19.08 20.91 13.81 15.44 13.08 7.74 6.89 6.17 7.34 5.57 7.86 10.02 9.67 6.84 7.20 6.41 6.43 193.24 193.24 119.39 119.386
Debt/Equity 0.01 0.01 0.01 0.01 0.08 0.09 0.09 0.10 0.12 0.03 0.03 0.03 0.03 0.02 0.02 0.03 0.04 0.00 0.00 0.00 0.004
Net Debt/Equity -0.99 -0.98 -1.00 -0.90 -0.53 -0.76 -0.62 -0.55 -0.67 -0.87 -0.84 -0.88 -0.89 -0.98 -0.97 -1.00 -1.01 -0.00 -0.00 0.00 0.003
Debt/Assets 0.01 0.01 0.01 0.01 0.07 0.07 0.08 0.08 0.10 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.03 0.00 0.00 0.00 0.004
Debt/EBITDA -0.04 -0.03 -0.03 -0.03 -0.21 -0.19 -0.18 -0.17 -0.17 -0.04 -0.04 -0.05 -0.05 -0.04 -0.04 -0.03 -0.05 -0.04 -0.03 -0.87 -0.865
Net Debt/EBITDA 5.84 4.46 3.63 2.66 1.33 1.73 1.23 0.94 1.00 1.08 1.05 1.40 1.54 1.57 1.40 1.31 1.29 0.37 0.28 -0.59 -0.588
Interest Coverage — — -12.02 -4.09 -4.35 -4.36 -5.77 -54.90 -61.85 -57.82 — -169.59 -146.78 -138.46 -134.41 — — — — -15.20 -15.197
Equity Multiplier 1.11 1.12 1.14 1.13 1.14 1.19 1.19 1.20 1.21 1.22 1.16 1.12 1.12 1.17 1.17 1.19 1.20 1.20 1.20 1.26 1.257
Cash Ratio snapshot only 0.176
Debt Service Coverage snapshot only -14.988
Cash to Debt snapshot only 0.320
FCF to Debt snapshot only -0.938
Defensive Interval snapshot only 99.4 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — 1.42 — 13.49 12.55 — — 6.58 5.17 — — — —
Receivables Turnover 1.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Payables Turnover 3.97 0.81 0.72 1.10 0.67 0.55 0.56 0.75 0.93 0.60 0.77 0.82 1.60 0.67 0.76 0.88 1.25 0.14 0.11 0.19 0.191
DSO 200 — — — — — — — — — — — — — — — — — — — —
DIO 0 -4079 0 0 0 -2590 0 0 0 257 0 27 29 0 0 55 71 0 0 0 0.0 days
DPO 92 448 504 333 548 664 650 486 394 607 477 445 228 549 480 415 292 2539 3274 1907 1906.9 days
Cash Conversion Cycle 108 — — — — — — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — -1.0% -1.0% -1.0% -1.0% — — — — — — — — — — — — — — — —
Net Income -76.7% -22.4% -37.0% -83.9% -83.4% -1.1% -54.2% -2.4% 5.1% 6.4% 13.5% 17.2% 30.3% 48.3% 44.9% 41.2% 32.9% 83.3% 155.5% 314.6% 314.56%
EPS -29.9% 10.0% -22.9% -83.2% -82.6% -1.1% -53.0% -1.3% 6.1% 7.3% 14.5% 21.3% 39.1% 56.1% 52.9% 51.9% 40.6% 38.4% 189.4% 6191.4% 6191.45%
FCF -1.4% -59.4% -36.6% -78.2% -81.6% -67.3% -61.9% 2.3% 19.9% 26.7% 34.6% 40.2% 45.8% 44.1% 40.1% 25.1% 12.1% 15.6% 10.1% -28.0% -27.97%
EBITDA -68.3% -93.0% -84.1% -78.2% -68.3% -33.5% -19.3% -12.2% -3.9% 2.8% 15.3% 31.5% 40.7% 39.6% 33.3% 18.9% 11.4% 2.5% -30.8% -37.4% -37.43%
Op. Income -69.9% -97.1% -87.2% -80.6% -69.8% -33.7% -19.6% -12.5% -4.4% 2.5% 14.7% 30.8% 40.0% 37.6% 31.6% 17.7% 8.3% 4.2% -27.1% -33.9% -33.86%
OCF Growth snapshot only -28.53%
Asset Growth snapshot only 215.83%
Equity Growth snapshot only 203.59%
Debt Growth snapshot only 34.93%
Shares Change snapshot only -94.93%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 1.0% 1.1% 66.9% 54.9% 55.6% 56.8% 16.8% 14.4% 12.0% -3.0% -31.4% -30.5% -32.8% -33.7% -35.3% -33.6% -33.9% 2.3% 2.4% 3.5% 3.52%
Assets 5Y 49.0% 55.0% 62.2% 69.6% 76.0% 79.6% 75.3% 98.9% 31.1% 27.3% 10.3% 8.9% 9.2% 9.5% -8.6% -8.6% -8.9% 1.2% 89.2% 1.2% 1.20%
Equity 3Y 99.1% 1.1% 79.4% 64.6% 66.2% 71.4% 16.4% 13.7% 10.8% -5.4% -33.3% -31.8% -32.9% -34.8% -35.7% -34.7% -34.9% 2.2% 2.4% 3.4% 3.45%
Book Value 3Y -42.6% -38.6% -46.6% 9.1% 36.6% 40.0% -1.0% 2.0% -0.5% -15.0% -36.1% -33.3% -36.2% -38.6% -39.4% -40.2% -40.4% 1.4% 2.4% 10.1% 10.06%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.41 0.12 0.12 0.12 0.12 0.00 0.00 0.00 0.00 0.05 0.05 0.05 0.05 1.00 1.00 1.00 1.00 0.66 0.66 0.66 0.662
Earnings Stability 0.00 0.03 0.28 0.51 0.68 0.77 0.91 0.93 0.91 0.88 0.90 0.76 0.55 0.31 0.26 0.10 0.04 0.42 0.43 0.43 0.429
Margin Stability — — — — — — — — — — — — — — — — — — — — —
Rev. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.91 0.85 0.50 0.50 0.50 0.50 0.99 0.98 0.97 0.95 0.93 0.88 0.81 0.82 0.84 0.87 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.27 0.41 -0.06 -0.15 -0.21 -0.29 -0.39 -0.34 -0.39 -0.61 -0.55 -0.28 -0.14 0.12 0.09 0.01 -0.02 1.44 1.98 1.79 1.788
Gross Margin Trend — — — — — — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — 1.3% 2.3% 2.1% 2.10%
Internal Growth Rate — — — — — — — — — — — — — — — — — -21.2% -2.1% -2.5% -2.50%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.07 1.21 0.95 0.89 0.90 0.77 0.88 0.90 0.85 0.80 0.85 0.75 0.74 0.87 0.92 0.96 0.96 -0.01 -0.01 -0.00 -0.004
FCF/OCF 1.06 1.09 1.13 1.24 1.26 1.34 1.28 1.16 1.12 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.003
FCF/Net Income snapshot only -0.004
CapEx/Revenue 47.1% — — — — — — — — — — — — — — — — — — — —
CapEx/Depreciation snapshot only 0.151
Accruals Ratio 0.02 0.05 -0.01 -0.03 -0.03 -0.09 -0.05 -0.04 -0.07 -0.11 -0.09 -0.13 -0.13 -0.06 -0.04 -0.02 -0.02 1.06 1.89 1.68 1.675
Sloan Accruals snapshot only 1.504
Cash Flow Adequacy snapshot only -384.680
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -2.1% -3.2% -0.1% -0.1% -0.1% -0.0% -0.0% -0.1% -0.1% -0.0% -0.1% -1.2% -1.0% -1.7% -1.9% -0.4% -0.5% -2.2% -4.3% -1.1% -1.08%
Total Shareholder Return -2.1% -3.2% -0.1% -0.1% -0.1% -0.0% -0.0% -0.1% -0.1% -0.0% -0.1% -1.2% -1.0% -1.7% -1.9% -0.4% -0.5% -2.2% -4.3% -1.1% -1.08%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.76 0.77 0.77 0.768
Interest Burden (EBT/EBIT) 1.01 0.75 0.89 1.10 1.11 1.20 1.15 1.00 1.01 1.16 1.16 1.20 1.17 0.99 0.97 0.88 0.91 -110.47 -151.63 -264.69 -264.693
EBIT Margin -6.76 — — — — — — — — — — — — — — — — — — — —
Asset Turnover 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.13 1.12 1.10 1.09 1.13 1.15 1.16 1.16 1.17 1.20 1.18 1.17 1.17 1.20 1.16 1.14 1.15 1.20 1.20 1.26 1.257
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.85 $-0.79 $-1.06 $-1.43 $-1.56 $-1.69 $-1.62 $-1.45 $-1.46 $-1.56 $-1.39 $-1.14 $-0.89 $-0.69 $-0.65 $-0.55 $-0.53 $25.63 $123.24 $3398.88 $3398.88
Book Value/Share $4.81 $4.64 $4.23 $3.73 $3.44 $3.09 $2.73 $2.39 $2.09 $1.62 $1.43 $1.46 $1.25 $1.08 $0.94 $0.80 $0.73 $40.15 $107.73 $3226.12 $3770.78
Tangible Book/Share $4.81 $4.64 $4.23 $3.73 $3.44 $3.09 $2.73 $2.39 $2.09 $1.62 $1.43 $1.46 $1.25 $1.08 $0.94 $0.80 $0.73 $28.06 $75.30 $2277.04 $2277.04
Revenue/Share $0.12 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.97 $-1.05 $-1.14 $-1.57 $-1.76 $-1.74 $-1.83 $-1.52 $-1.39 $-1.26 $-1.18 $-0.86 $-0.66 $-0.60 $-0.61 $-0.53 $-0.51 $-0.23 $-0.66 $-13.39 $-15.65
OCF/Share $-0.91 $-0.96 $-1.01 $-1.27 $-1.40 $-1.30 $-1.43 $-1.30 $-1.24 $-1.25 $-1.17 $-0.86 $-0.66 $-0.59 $-0.60 $-0.53 $-0.51 $-0.23 $-0.66 $-13.35 $-15.29
Cash/Share $4.79 $4.59 $4.25 $3.40 $2.10 $2.61 $1.94 $1.56 $1.64 $1.47 $1.26 $1.33 $1.15 $1.08 $0.94 $0.82 $0.76 $0.12 $0.33 $4.57 $5.34
EBITDA/Share $-0.81 $-1.02 $-1.16 $-1.27 $-1.36 $-1.36 $-1.37 $-1.41 $-1.40 $-1.31 $-1.15 $-0.92 $-0.73 $-0.67 $-0.65 $-0.61 $-0.57 $-0.30 $-1.04 $-16.50 $-16.50
Debt/Share $0.03 $0.03 $0.04 $0.03 $0.29 $0.26 $0.25 $0.24 $0.24 $0.06 $0.05 $0.04 $0.04 $0.02 $0.02 $0.02 $0.03 $0.01 $0.04 $14.27 $14.27
Net Debt/Share $-4.75 $-4.56 $-4.21 $-3.37 $-1.81 $-2.35 $-1.69 $-1.32 $-1.40 $-1.41 $-1.21 $-1.28 $-1.12 $-1.05 $-0.92 $-0.80 $-0.73 $-0.11 $-0.29 $9.71 $9.71
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.777
Altman Z-Prime snapshot only 6.997
Piotroski F-Score 4 2 1 1 1 1 1 1 1 2 3 3 4 4 3 3 2 4 5 5 5
Beneish M-Score — — — — — — — — — — — — — — — — — — — — —
Ohlson O-Score snapshot only -12.731
ROIC (Greenblatt) snapshot only -0.54%
Net-Net WC snapshot only $2275.26
EVA snapshot only $-406783152.33
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 72.96 74.15 61.93 63.91 64.09 65.50 64.75 65.05 65.45 65.69 76.21 65.43 65.07 65.32 65.56 76.16 75.87 59.12 58.99 42.63 42.632
Credit Grade snapshot only 12
Credit Trend snapshot only -33.532
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 38
Sector Credit Rank snapshot only 34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms